Status:
COMPLETED
Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension
Lead Sponsor:
AstraZeneca
Conditions:
Acute Coronary Syndromes
Eligibility:
All Genders
Brief Summary
This study is to describe the long-term antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome in China.
Detailed Description
This study is to describe the long-term (3 to 5 years after the acute coronary syndrome index event) antithrombotic management patterns in a real-life setting for patients hospitalized with an acute c...
Eligibility Criteria
Inclusion
- Written informed consent has been provided.
- Contact Order Form has been provided
- Aged 18 years or older.
- Enrolled in EPICOR Asia study and completed the 2 year follow-up.
Exclusion
- Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances, alcohol or drug abuse).
- Already included in the EPICOR Asia-China Extension observational study.
- Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.
- Current participation in an interventional clinical trial.
- Patients receiving ticagrelor beyond 12 months and other off label use.
Key Trial Info
Start Date :
December 17 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 5 2017
Estimated Enrollment :
2334 Patients enrolled
Trial Details
Trial ID
NCT02305680
Start Date
December 17 2014
End Date
April 5 2017
Last Update
September 17 2018
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Baoding, China
2
Research Site
Beijing, China
3
Research Site
Changzhi, China
4
Research Site
Chongqing, China